Lynozyfic 61755-0054
Generic: Linvoseltamab-Gcpt
Product NDC
61755-0054- Manufacturer
- Regeneron Pharmaceuticals, Inc.
- Dosage Form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- July 2, 2025
- Listing Expires
- December 31, 2026
- Application
- BLA761400
Need to source Lynozyfic? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Linvoseltamab | 5 mg/2.5mL |
Drug Class
Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC]
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (61755-054-01) / 2.5 mL in 1 VIAL, SINGLE-DOSE (61755-054-00)